Company intelligence / Profile preview

McMurray Medical Group

Minneapolis, Minnesota, United Statesmcmurraymed.com ↗

Ownership: Private
Employees: ~2
Development stage: Other

Overview

McMurray Medical has developed and commercialized the McMurray Enhanced Airway (MEA), an innovative distal pharyngeal airway device designed to improve patient safety and outcomes during anesthesia by addressing upper airway obstruction. The MEA is FDA-listed and used in hospitals and healthcare facilities across the U.S. It has won multiple innovation awards for its impact on clinical practice[2][5][7].

Therapeutic areas: Pulmonology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on McMurray Medical Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on McMurray Medical Group.

Explore the full profile